Clinical Trials in San Francisco

Showing 4181-4200 of 12,991 trials

Ruxolitinib in Operable Head and Neck Cancer

NCT03153982

The purpose of this study is to assess the safety and efficacy of ruxolitinib in patients with operable Head and neck squamous cell carcinoma (HNSCC) who are planned for definitive surgery.

Head and Neck Squamous Cell Carcinoma

University of California, San Francisco16 participantsStarted Jun 2018

Tucson, Arizona, United States • San Francisco, California, United States

COMPLETEDNA< 1 mile

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

NCT05817045

This is a randomized, double-blind, sham controlled, stratified, pivotal efficacy and safety study of the EmitBio RD-X19 treatment device in Individuals 40 Years of age and older with Mild COVID-19 in the at-home setting.

COVID-19

EmitBio Inc.330 participantsStarted Apr 2023

Mesa, Arizona, United States • Phoenix, Arizona, United States • Anaheim, California, United States +45 more locations

Ruxolitinib in Operable Head and Neck Cancer

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

Find Trials by Condition in San Francisco

A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)

Imaging Immune Activation in COVID-19

Pediatric Arthritis Study of Certolizumab Pegol

Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Participants With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer

Glasdegib for Chronic Graft-Versus-Host Disease

Investigation of Clot in Ischemic Stroke and Hematoma Evacuation

Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma

First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms

A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy